Emily
Editor, Senior Moderator
http://jid.oxfordjournals.org/content/188/11/1618.short
Full text at link. :tiphat:
Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event J Infect Dis. (2003) 188 (11): 1618-1629 doi:10.1086/379724
Thomas W. Geisbert1,
Howard A. Young3,
Peter B. Jahrling2,
Kelly J. Davis2,
Elliott Kagan4 and
Lisa E. Hensley1
+ Author Affiliations
1Virology Division and
2Headquarters, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick,
3Cellular and Molecular Immunology Section, Laboratory of Experimental Immunology, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, and
4Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Abstract
Disseminated intravascular coagulation is a prominent manifestation of Ebola virus (EBOV) infection. Here, we report that tissue factor (TF) plays an important role in triggering the hemorrhagic complications that characterize EBOV infections. Analysis of samples obtained from 25 macaques showed increased levels of TF associated with lymphoid macrophages, whereas analysis of peripheral blood?cell RNA showed increased levels of TF transcripts by day 3. Plasma from macaques contained increased numbers of TF-expressing membrane microparticles. Dysregulation of the fibrinolytic system developed during the course of infection, including a rapid decrease in plasma levels of protein C. Infection of primary human monocytes/macrophages (PHMs) was used to further evaluate the role of TF in EBOV infections. Analysis of PHM RNA at 1?48 h showed increased TF transcripts, whereas levels of TF protein were dramatically increased by day 2. Thus, chemotherapeutic strategies aimed at controlling overexpression of TF may ameliorate the effects of EBOV hemorrhagic fever
Footnotes
Presented in part: XII International Congress of Virology, Paris, 27 July?1 August 2002 (symposium V-293)
The views, opinions, and findings contained herein are those of the authors and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation
Received February 12, 2003.
Accepted June 9, 2003.
Full text at link. :tiphat: